The Clinical Core ofthe Michigan Diabetes Research Center (MDRC) provides expertise and services to support basic biomedical research and research that focuses on the translation of basic science findings into potential therapeutics and their testing in eariy phase clinical trials (type 1 translational research).
The Specific Aims of the Clinical Core are: Maintain and continuously update a Diabetes Research Registry to facilitate the recruitment of diabetic subjects into clinical studies Support a Chemistry Laboratory to provide expertise and state-of-the-art analytical services to MDRC investigators Provide both routine and non-routine biostatistical services to assist MDRC investigators in experimental design, data management, and data analysis. The proposed user base for the Clinical Core are investigators engaged in basic biomedical and type 1 translational research focused on prediabetes, the pathogenesis and prevention of diabetes, diabetes treatments, and the prevention and control of diabetic complications including retinopathy, nephropathy, neuropathy and cardiovascular disease. The objective of the Clinical Core is to provide expertise and state-of-the-art shared resources to accelerate the pace and improve the efficiency and cost-effectiveness of biomedical and type 1 translational research in diabetes.

Public Health Relevance

The Clinical Core ofthe Michigan Diabetes Research Center (MDRC) provides expertise and services to support basic biomedical research and research that focuses on the translation of basic science findings into potential therapeutics and their testing in eariy phase clinical trials (type 1 translational research). The Specific Aims of the Clinical Core are: Maintain and continuously update a Diabetes Research Registry to facilitate the recruitment of diabetic subjects into clinical studies Support a Chemistry Laboratory to provide expertise and state-of-the-art analytical services to MDRC investigators Provide both routine and non-routine biostatistical services to assist MDRC investigators in experimental design, data management, and data analysis. The proposed user base for the Clinical Core are investigators engaged in basic biomedical and type 1 translational research focused on prediabetes, the pathogenesis and prevention of diabetes, diabetes treatments, and the prevention and control of diabetic complications including retinopathy, nephropathy, neuropathy and cardiovascular disease. The objective of the Clinical Core is to provide expertise and state-of-the-art shared resources to accelerate the pace and improve the efficiency and cost-effectiveness of biomedical and type 1 translational research in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020572-37
Application #
8617164
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
37
Fiscal Year
2014
Total Cost
$137,798
Indirect Cost
$49,182
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Brown, Rebecca J; Oral, Elif A; Cochran, Elaine et al. (2018) Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine 60:479-489
Lee, Pearl G; Damschroder, Laura J; Holleman, Robert et al. (2018) Older Adults and Diabetes Prevention Programs in the Veterans Health Administration. Diabetes Care 41:2644-2647
Spencer, Michael S; Kieffer, Edith C; Sinco, Brandy et al. (2018) Outcomes at 18 Months From a Community Health Worker and Peer Leader Diabetes Self-Management Program for Latino Adults. Diabetes Care 41:1414-1422
Sujkowski, Alyson; Wessells, Robert (2018) Using Drosophila to Understand Biochemical and Behavioral Responses to Exercise. Exerc Sport Sci Rev 46:112-120
Ma, Fuqiang; Chung, Meng Ting; Yao, Yuan et al. (2018) Efficient molecular evolution to generate enantioselective enzymes using a dual-channel microfluidic droplet screening platform. Nat Commun 9:1030
Pieber, Thomas R; Marso, Steven P; McGuire, Darren K et al. (2018) DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia 61:58-65
McEwen, Laura N; Lee, Pearl G; Backlund, Jye-Yu C et al. (2018) Recording of Diabetes on Death Certificates of Decedents With Type 1 Diabetes in DCCT/EDIC. Diabetes Care 41:e158-e160
Ramos, Carla J; Lin, Chengmao; Liu, Xuwen et al. (2018) The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability. J Biol Chem 293:717-730
Park, Min-Jung; Iyer, Sapna; Xue, Xiang et al. (2018) HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas. Gastroenterology 154:1630-1634.e3
Sucularli, Ceren; Thomas, Peedikayil; Kocak, Hande et al. (2018) High-throughput gene expression analysis identifies p53-dependent and -independent pathways contributing to the adrenocortical dysplasia (acd) phenotype. Gene 679:219-231

Showing the most recent 10 out of 1823 publications